Chuong J J, DuBovik S, McCallum R W
Dig Dis Sci. 1984 Dec;29(12):1105-8. doi: 10.1007/BF01317084.
Achalasia has been purported to be a risk factor for the development of esophageal carcinoma. To test the validity of this association at the Yale-New Haven Hospital (YNHH) and its major affiliate, the West Haven Veterans Administration Medical Center (WHVA), two approaches were employed: (1) a prospective study identifying 100 subjects with manometrically documented achalasia for the development of esophageal cancer; (2) a retrospective review of esophageal cancer patients admitted to the YNHH and the WHVA from 1971 through 1981 for any evidence of achalasia. No cases of esophageal carcinoma were identified in the 91 evaluable achalasics. No case of achalasia was found or even suggested in association with the 153 cases of esophageal cancer reviewed. Our findings do not substantiate the association of achalasia and esophageal carcinoma. The clinical implications of this conclusion on surveillance and follow-up of achalasia patients are discussed.
贲门失弛缓症被认为是食管癌发生的一个危险因素。为了在耶鲁 - 纽黑文医院(YNHH)及其主要附属医院西黑文退伍军人管理局医疗中心(WHVA)检验这种关联的有效性,采用了两种方法:(1)一项前瞻性研究,确定100名经测压记录确诊为贲门失弛缓症的受试者,观察其是否发生食管癌;(2)对1971年至1981年期间入住YNHH和WHVA的食管癌患者进行回顾性研究,以寻找贲门失弛缓症的任何证据。在91例可评估的贲门失弛缓症患者中未发现食管癌病例。在回顾的153例食管癌病例中,未发现或甚至未提示有贲门失弛缓症病例。我们的研究结果不支持贲门失弛缓症与食管癌之间的关联。本文讨论了这一结论对贲门失弛缓症患者监测和随访的临床意义。